drugset / Trial / NCT06568302
The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial
NaSequentialOpen-labelTreatment
Summary
The purpose of the study is to evaluate the efficacy, safety, tolerability and pharmacokinetic (PK) profile of prophylactic SerpinPC in participants with hemophilia
Timeline
- Start
- 2024-07-11
- Primary completion
- 2025-01-29
- Completion
- 2025-01-29
Outcome
Outcome not reported
Stopped (Business): “Study terminated due to business and strategic decision.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SerpinPC | Unknown | 1.2 mg/kg | Subcutaneous |